Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer.

PURPOSE The number of patients receiving chemotherapy near the end of life is increasing, as are concerns about goals of treatment, toxicity, and costs. We sought to determine the available sources of knowledge, the choices, and concerns of actual patients, and how patients balanced competing issues. METHODS We used a literature search from 1980 to present. RESULTS Available patient sources provide little information about prognosis, choices, alternatives, consequences, or how to choose. Many patients would choose chemotherapy for a small benefit in health outcomes, and for a smaller benefit than perceived by their health care providers for their own treatment. Adverse effects are less a concern for patients than for their well health care providers. There are no decision aids to assist patients with metastatic disease in making their choices, such as there are for adjuvant breast therapy. CONCLUSION The perspective of the patient is different from that of a well person. Patients are willing to undergo treatments that have small benefits with major toxicity. Receiving realistic information about the different options of care and the likelihood of successful treatment or adverse effects is difficult. These factors may explain some of the increased use of chemotherapy near the end of life. Decision aids and honest, unbiased sources to inform patients of their prognosis, choices, consequences, typical outcomes, and ways to make decisions are needed. More prospective information about how patients make their choices, and what they would consider a good choice, would assist informed decision making.

[1]  Victor R Fuchs,et al.  Health Care Expenditures Reexamined , 2005, Annals of Internal Medicine.

[2]  Thomas Bodenheimer,et al.  High and Rising Health Care Costs. Part 4: Can Costs Be Controlled While Preserving Quality? , 2005, Annals of Internal Medicine.

[3]  Thomas Bodenheimer,et al.  High and Rising Health Care Costs. Part 1: Seeking an Explanation , 2005, Annals of Internal Medicine.

[4]  P. Ravdin,et al.  Decreased Use of Adjuvant Breast Cancer Therapy in a Randomized Controlled Trial of a Decision Aid with Individualized Risk Information , 2005, Medical decision making : an international journal of the Society for Medical Decision Making.

[5]  Phyllis N Butow,et al.  Communicating with realism and hope: incurable cancer patients' views on the disclosure of prognosis. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  M. Adachi,et al.  Patients preferences in chemotherapy for advanced non-small-cell lung cancer. , 2005, Internal medicine.

[7]  M. Little,et al.  While there's life ... hope and the experience of cancer. , 2004, Social science & medicine.

[8]  Dennis F. Moore,et al.  Cancer patients' expectations of experiencing treatment‐related side effects , 2004, Cancer.

[9]  Deborah Schrag,et al.  The price tag on progress--chemotherapy for colorectal cancer. , 2004, The New England journal of medicine.

[10]  M. Murray,et al.  Decision support: helping patients and families to find a balance at the end of life. , 2004, International journal of palliative nursing.

[11]  T. Shanafelt,et al.  Are chemotherapy response rates related to treatment-induced survival prolongations in patients with advanced cancer? , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  E. Bruera,et al.  Palliative care inpatient service in a comprehensive cancer center: clinical and financial outcomes. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  J. Skinner,et al.  Use of hospitals, physician visits, and hospice care during last six months of life among cohorts loyal to highly respected hospitals in the United States , 2004, BMJ : British Medical Journal.

[14]  T. Louis,et al.  Medicare Program Expenditures Associated with Hospice Use , 2004, Annals of Internal Medicine.

[15]  C. Earle,et al.  Trends in the aggressiveness of cancer care near the end of life. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Thomas J. Smith,et al.  A high-volume specialist palliative care unit and team may reduce in-hospital end-of-life care costs. , 2003, Journal of palliative medicine.

[17]  E. Bradley,et al.  What is a Good Death? Minority and Non-minority Perspectives , 2003, Journal of palliative care.

[18]  E. Emanuel,et al.  Chemotherapy Use among Medicare Beneficiaries at the End of Life , 2003, Annals of Internal Medicine.

[19]  L. Lyckholm,et al.  Truth or consequences: what to do when the patient doesn't want to know. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  J. Baron,et al.  The Role of Physicians’ Recommendations in Medical Treatment Decisions , 2002, Medical decision making : an international journal of the Society for Medical Decision Making.

[21]  M. Brundage,et al.  Cancer patients' attitudes toward treatment options for advanced non-small cell lung cancer: implications for patient education and decision support. , 2001, Patient education and counseling.

[22]  R. Osborne,et al.  Who wants second‐line, palliative chemotherapy? , 2001, Psycho-oncology.

[23]  Nicholas Christakis,et al.  Prognostic Disclosure to Patients with Cancer near the End of Life , 2001, Annals of Internal Medicine.

[24]  J. Finkelstein,et al.  Patients with advanced cancer: a survey of the understanding of their illness and expectations from palliative radiotherapy for symptomatic metastases. , 2001, Clinical oncology (Royal College of Radiologists (Great Britain)).

[25]  S. Gottlieb.  Chemotherapy may be overused at the end of life , 2001, BMJ : British Medical Journal.

[26]  T. Hak,et al.  Collusion in doctor-patient communication about imminent death: an ethnographic study , 2000, BMJ : British Medical Journal.

[27]  T. Hak,et al.  Collusion in doctor-patient communication about imminent death: an ethnographic study. , 2000, The Western journal of medicine.

[28]  Ian Graham,et al.  Development and evaluation of a decision aid for patients with stage IV non‐small cell lung cancer , 2000, Health expectations : an international journal of public participation in health care and health policy.

[29]  Nicholas Christakis,et al.  In Search of a Good Death: Observations of Patients, Families, and Providers , 2000, Annals of Internal Medicine.

[30]  C. Brunelli,et al.  The difficult choice of chemotherapy in patients with unresectable non-small-cell lung cancer , 2000, Supportive Care in Cancer.

[31]  N. Christakis,et al.  Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study , 2000, BMJ : British Medical Journal.

[32]  W. Levinson,et al.  Informed decision making in outpatient practice: time to get back to basics. , 1999, JAMA.

[33]  Sallie Newell,et al.  How well do Medical oncologists' perceptions reflect their patients' reported physical and psychosocial problems? , 1998, Cancer.

[34]  H. Welch,et al.  Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews , 1998, BMJ.

[35]  T. Smith,et al.  Telling the truth about terminal cancer. , 1998, JAMA.

[36]  M. Somerfield,et al.  Would oncologists want chemotherapy if they had non-small-cell lung cancer? , 1998, Oncology.

[37]  S. Ahmedzai,et al.  What investigations and procedures do patients in hospices want? Interview based survey of patients and their nurses , 1997, BMJ.

[38]  A. Hopkins,et al.  Malignant cerebral glioma—I: Survival, disability, and morbidity after radiotherapy , 1996, BMJ.

[39]  A. Hopkins,et al.  Malignant cerebral glioma—II: Perspectives of patients and relatives on the value of radiotherapy , 1996, BMJ.

[40]  R. Bremnes,et al.  Cancer patients, doctors and nurses vary in their willingness to undertake cancer chemotherapy. , 1995, European journal of cancer.

[41]  S. Murphy,et al.  Ethnicity and attitudes toward patient autonomy. , 1995, JAMA.

[42]  D. Cella,et al.  Someone to live for: social well-being, parenthood status, and decision-making in oncology. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  Roger B. Davis,et al.  The Impact of Serious Illness on Patients' Families , 1994 .

[44]  E. Cook,et al.  The impact of serious illness on patients' families. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. , 1994, JAMA.

[45]  W. Gregory,et al.  Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public. , 1990, BMJ.

[46]  W. Mackillop,et al.  Cancer patients' perceptions of their disease and its treatment. , 1988, British Journal of Cancer.

[47]  Leonard Finegold,et al.  References Rapid responses , 2006 .

[48]  F. Ferris,et al.  EPEC. Education for Physicians on End-of-Life Care. , 2002, The American journal of hospice & palliative care.

[49]  T. Smith,et al.  Why academic divisions of hematology/oncology are in trouble and some suggestions for resolution. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[50]  E. Lamont,et al.  Paradoxes in cancer patients' advance care planning. , 2000, Journal of palliative medicine.

[51]  V. Georgiou,et al.  The impact of cytotoxic chemotherapy--perspectives from patients, specialists and nurses. , 1992, European journal of cancer.

[52]  L. Siminoff,et al.  Factors affecting treatment decisions for a life-threatening illness: the case of medical treatment of breast cancer. , 1991, Social science & medicine.